{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:44:13Z","timestamp":1794620653468,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ID- 2021-8630"],"award-info":[{"award-number":["ID- 2021-8630"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018761","name":"Indo-German Science and Technology Centre","doi-asserted-by":"publisher","award":["IGSTC\/PECFAR\/Call 2022\/USAK\/36\/2022\\u201323\/Award letter\/488"],"award-info":[{"award-number":["IGSTC\/PECFAR\/Call 2022\/USAK\/36\/2022\\u201323\/Award letter\/488"]}],"id":[{"id":"10.13039\/501100018761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118512","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T15:20:12Z","timestamp":1756740012000},"page":"118512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK\/SREBP1\/NF-\u03baB\/TGF-\u03b2 pathways in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-8646","authenticated-orcid":false,"given":"Poonam","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9264-8081","authenticated-orcid":false,"given":"Sumeet Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-0931","authenticated-orcid":false,"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umashanker","family":"Navik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2025.118512_bib1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2025.118512_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000488","article-title":"Estimating the economic impact of comorbidities in patients with MASH and defining high-cost burden in patients with noncirrhotic MASH","volume":"8","author":"Younossi","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2025.118512_bib3","doi-asserted-by":"crossref","unstructured":"H. The lancet gastroenterology, resmetirom for NASH: balancing promise and prudence, Lancet Gastroenterol. Hepatol. 9(4), 2024. p. 273..","DOI":"10.1016\/S2468-1253(24)00049-9"},{"key":"10.1016\/j.biopha.2025.118512_bib4","unstructured":"FDA, \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease\u3009, 2024."},{"issue":"2","key":"10.1016\/j.biopha.2025.118512_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118512_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-020-0225-0","article-title":"AMPK against NASH","volume":"21","author":"Strzyz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118512_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.biopha.2025.118512_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096147","article-title":"Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1\u03b1 in db\/db mice","volume":"9","author":"Hong","year":"2014","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.biopha.2025.118512_bib10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.biopha.2018.10.161","article-title":"Puerarin attenuates neurological deficits via Bcl-2\/Bax\/cleaved caspase-3 and Sirt3\/SOD2 apoptotic pathways in subarachnoid hemorrhage mice","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.biopha.2025.118512_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2407-9-100","article-title":"Regulation of HSP27 on NF-kappaB pathway activation May be involved in metastatic hepatocellular carcinoma cells apoptosis","volume":"9","author":"Guo","year":"2009","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/j.biopha.2025.118512_bib13","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.4049\/jimmunol.175.12.8303","article-title":"TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK","volume":"175","author":"Han","year":"2005","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2025.118512_bib14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1177\/2050640618804444","article-title":"Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease","volume":"6","author":"Rau","year":"2018","journal-title":"U. Eur. Gastroenterol. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41438-021-00640-w","article-title":"Sclareol and linalyl acetate are produced by glandular trichomes through the MEP pathway","volume":"8","author":"Chalvin","year":"2021","journal-title":"Hortic. Res."},{"key":"10.1016\/j.biopha.2025.118512_bib16","article-title":"The bioactivities of sclareol: a mini review","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118512_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/s30800276","article-title":"Measurement of nitric oxide production in biological systems by using Griess reaction assay","volume":"3","author":"Sun","year":"2003","journal-title":"Sensors"},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib18","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3877","article-title":"A simple microplate assay for reactive oxygen species generation and rapid cellular protein normalization","volume":"11","author":"Ng","year":"2021","journal-title":"Bio Protoc."},{"key":"10.1016\/j.biopha.2025.118512_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.intimp.2016.12.026","article-title":"Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling","volume":"44","author":"Hsieh","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2025.118512_bib20","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/ptr.7465","article-title":"Sclareol ameliorates hyperglycemia-induced renal injury through inhibiting the MAPK\/NF-\u03baB signaling pathway","volume":"36","author":"Han","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2025.118512_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231223644","article-title":"Sclareol ameliorates liver injury by inhibiting nuclear factor-kappa B\/NOD-like receptor protein 3-mediated inflammation and lipid metabolism disorder in diabetic mice","volume":"37","author":"Tang","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"8","key":"10.1016\/j.biopha.2025.118512_bib22","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1002\/tox.24291","article-title":"Betaine ameliorates doxorubicin-induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK\/Nrf2\/TGF-\u03b2 expression","volume":"39","author":"Singh","year":"2024","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.biopha.2025.118512_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.talanta.2018.12.049","article-title":"A sensitive GC\/MS detection method for analyzing microbial metabolites short chain fatty acids in fecal and serum samples","volume":"196","author":"Zhang","year":"2019","journal-title":"Talanta"},{"issue":"23","key":"10.1016\/j.biopha.2025.118512_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201801401","article-title":"Dietary supplementation of methyl donor l-Methionine alters epigenetic modification in type 2 diabetes","volume":"63","author":"Navik","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.biopha.2025.118512_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2025.118512_bib26","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1039\/D1FO03403K","article-title":"l-Methionine supplementation attenuates high-fat fructose diet-induced non-alcoholic steatohepatitis by modulating lipid metabolism, fibrosis, and inflammation in rats","volume":"13","author":"Navik","year":"2022","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s43856-024-00465-3","article-title":"Transcriptomics-driven metabolic pathway analysis reveals similar alterations in lipid metabolism in mouse MASH model and human","volume":"4","author":"Tsouka","year":"2024","journal-title":"Commun. Med."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14010012","article-title":"Lipid metabolism in metabolic-associated steatotic liver disease (MASLD)","volume":"14","author":"Syed-Abdul","year":"2023","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.biopha.2025.118512_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10896","article-title":"A high-fat, high-fructose diet induced hepatic steatosis, renal lesions, dyslipidemia, and hyperuricemia in non-obese rats","volume":"8","author":"Yustisia","year":"2022","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.biopha.2025.118512_bib30","first-page":"287","article-title":"First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid","volume":"54","author":"Ighodaro","year":"2018","journal-title":"Alex. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2025.118512_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101383","article-title":"Regulation and metabolic significance of de novo lipogenesis in adipose tissues","volume":"10","author":"Song","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.biopha.2025.118512_bib32","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.biopha.2025.118512_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1742-4658.2008.06806.x","article-title":"SREBPs: physiology and pathophysiology of the SREBP family","volume":"276","author":"Shimano","year":"2009","journal-title":"Febs J."},{"issue":"5","key":"10.1016\/j.biopha.2025.118512_bib34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1039\/b603600g","article-title":"The type I fatty acid and polyketide synthases: a tale of two megasynthases","volume":"24","author":"Smith","year":"2007","journal-title":"Nat. Prod. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2025.118512_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0899-9007(99)00266-X","article-title":"Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology","volume":"16","author":"Kuhajda","year":"2000","journal-title":"Nutrition"},{"issue":"16","key":"10.1016\/j.biopha.2025.118512_bib36","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00018-005-5121-4","article-title":"Acetyl-coenzyme a carboxylase: crucial metabolic enzyme and attractive target for drug discovery","volume":"62","author":"Tong","year":"2005","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2025.118512_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/DMSO.S219013","article-title":"Therapeutic targets of hypercholesterolemia: HMGCR and LDLR","volume":"12","author":"Ma","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","article-title":"Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics","volume":"7","author":"Duan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0043-118666","article-title":"Pivotal role of TNF-\u03b1 in the development and progression of nonalcoholic fatty liver disease in a murine model","volume":"50","author":"Kakino","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.biopha.2025.118512_bib40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.yexmp.2011.08.001","article-title":"Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation","volume":"91","author":"Kirovski","year":"2011","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.biopha.2025.118512_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8833287","article-title":"Pentraxin 3 and the TyG index as two novel markers to diagnose NAFLD in children","author":"Ye","year":"2021","journal-title":"Dis. Mark."},{"issue":"9","key":"10.1016\/j.biopha.2025.118512_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/met.2015.0046","article-title":"Plasma pentraxin 3 differentiates nonalcoholic steatohepatitis (NASH) from Non-NASH","volume":"13","author":"Boga","year":"2015","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/hep4.1799","article-title":"Direct AMPK activation corrects NASH in rodents through metabolic effects and direct action on inflammation and fibrogenesis","volume":"6","author":"Gluais-Dagorn","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"12","key":"10.1016\/j.biopha.2025.118512_bib44","article-title":"Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease: a phase 1b study","volume":"2","author":"Fouqueray","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2025.118512_bib45","doi-asserted-by":"crossref","unstructured":"C.J. Green, S.A. Parry, P.J. Gunn, C.D.L. Ceresa, F. Rosqvist, M.-E. Pich\u00e9, L. Hodson, Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models, 41(1) 2020.","DOI":"10.1515\/hmbci-2018-0038"},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-12-20","article-title":"Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease","volume":"12","author":"Chavez-Tapia","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2025.118512_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2128-8_1","article-title":"Histopathological diagnosis of nonalcoholic steatohepatitis (NASH)","volume":"2455","author":"Giashuddin","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biopha.2025.118512_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117997","article-title":"IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease","volume":"256","author":"Xiao","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010360","article-title":"Antrodan alleviates high-fat and high-fructose diet-induced fatty liver disease in C57BL\/6 mice model via AMPK\/Sirt1\/SREBP-1c\/PPAR\u03b3 pathway","volume":"21","author":"Chyau","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118512_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.587189","article-title":"ChREBP-Mediated regulation of lipid metabolism: involvement of the gut microbiota, liver, and adipose tissue","volume":"11","author":"Iizuka","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.biopha.2025.118512_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103766","article-title":"PHLPP1 promotes neutral lipid accumulation through AMPK\/ChREBP-dependent lipid uptake and fatty acid synthesis pathways","volume":"25","author":"Balamurugan","year":"2022","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.biopha.2025.118512_bib52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin Liver Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib53","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gene.2015.03.057","article-title":"ChREBP and LXR\u03b1 mediate synergistically lipogenesis induced by glucose in porcine adipocytes","volume":"565","author":"Zhang","year":"2015","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2007.12.004","article-title":"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER","volume":"200","author":"Polisecki","year":"2008","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.biopha.2025.118512_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061780","article-title":"The role of Low-Density lipoprotein Receptor-Related protein 1 in lipid metabolism, glucose homeostasis and inflammation","volume":"19","author":"Actis Dato","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.118512_bib56","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.biopha.2025.118512_bib57","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3350\/cmh.2017.0030","article-title":"Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis","volume":"24","author":"Ando","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2025.118512_bib58","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.biopha.2017.11.117","article-title":"Stachydrine ameliorates carbon tetrachloride-induced hepatic fibrosis by inhibiting inflammation, oxidative stress and regulating MMPs\/TIMPs system in rats","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225007061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:05:10Z","timestamp":1772823910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225007061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S0753332225007061"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118512","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclareol mitigates steatosis, inflammation, and fibrosis through the regulation of AMPK\/SREBP1\/NF-\u03baB\/TGF-\u03b2 pathways in metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118512"}}